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Accidental total spinal block (2)
To the Editor: In their discussion of the possible cause of the total spinal block following an "epidural" test dose of 1.5% lidocaine 3 ml with epinephrine 1:200,000 15 ~tg, the authors did not consider iso-or hypobaricity of the anaesthetic in a sitting patient and a cephalad-threaded catheter, l In 30 healthy, nonfasting parturients, cerebrospinal (CSF) specific gravity ranged from 1.0009 to 1.0063. 2 Although the patient described had received one litre of/v electrolyte solution, she most likely had been fasting for some time raising her CSF specific gravity to the upper range. The specific gravity of 1.5% lidocaine is 1.0064 at room temperature (25~ but the specific gravity of drugs is consistently lower at body temperature (37~ Thus, the specific gravity of 2% chloroprocaine CE measures 1.010 at 25~ but 1.0044 at 37~ 3 Since a small volume of drug injected into the CSF at room temperature approaches body temperature within seconds, 4 one may assume that the lidocaine specific gravity in this case was at a low level.
A similar complication was repeated following accidental intrathecal injection of 2.5 ml of 2% chloroprocaine through a cephalad-threaded catheter in a parturient in a head-up position. 3 Since most local anaesthetics are hypobaric at body temperature, test doses should not be administered with the patient in a sitting position when administration of the block is difficult. 
Accidental total spinal block (3)
To the Editor: I would like to challenge the statement by Palkar et al. ~ that 15 Isg epinephrine must be added to epidural test solutions to rule out intravascular injection. Although this may well be true for young, calm or premedicated adult surgical patients not receiving [3-blockers, this cannot be extrapolated to other patient groups such as pregnant, in particular, labouring women. In order to be clinically useful, an intravascular injection of an epinephrine containing test dose must consistently produce tachycardia in a patient who has an otherwise stable heart rate. Chestnut 2 found that 50% of labouring women had at least one spontaneous heart rate acceleration during the period of epidural placement. Injecting either saline or 15 ~g epinephrine /v into labouring women Leighton 3 found the heart rate response to be neither specific nor sensitive. In the group receiving saline, 20% had an increase in heart rate, yet only 50% of those actually given epinephrine showed an increase.
In addition, the test dose must be safe, both for the mother and fetus. Hood 4 showed intravenous solutions containing 10-20 Is injected into pregnant ewes consistently decreased uterine blood flow to 55-65% of control, but without evidence of fetal compromise. However, Leighton 3 demonstrated signs of fetal distress in two of ten patients receiving/v epinephrine. In addition, she questioned the safety of epinephrine in pre-eclamptic patients.
Clearly the role of epinephrine in the obstetric epidural is controversial. Many centres, ours included, do not routinely use an epinephrine containing test dose in pregnant patients. The alternatives to test for intravascular catheter placement are either to use an air test dose with a precordial Doppler monitor, or a plain local anaesthetic test dose sufficient to have a reasonable probability of eticiting mild systemic symptoms should/v injection occur, without leading to too high a block in the average patient in the event of an unintentional subarachnoid injection. Such a test dose would be 3 ml of 1.5 or 2% tidocaine.
However, as this case report showed, high spinal blockade can occur with as tittle as 45 mg subarachnoid lidocaine. This illustrates that even the most conscientiously planned test dose does not replace a high index of suspicion regarding catheter placement, slow titration of epidural local anaesthetic, vigilance, and preparedness of the unexpected.
